General – C2 Pharma

C2 PHARMA Marks 10th Year Anniversary Attendance at CPhI Milan with Expanded Ophthalmic API Portfolio

Posted on 24. September 202424. September 2024 by admin_c2p

C2 PHARMA EXPANDS OPHTHALMIC API PORTFOLIO WITH NAPHAZOLINE HYDROCHLORIDE LAUNCH

Posted on 12. September 2024 by admin_c2p

C2 PHARMA x PharmaSource Ophthalmics Buyer Guide

Posted on 15. February 202415. February 2024 by admin_c2p

Optimizing the Total Cost of Ownership by C2 PHARMA’s CEO, Andrew Badrot

Posted on 30. October 202330. October 2023 by admin_c2p

Celebrating a Milestone: Cyclopentolate CEP approval

Posted on 6. July 2023 by admin_c2p

Assuring security of supply for phyto-APIs

Posted on 17. March 2023 by Kaitlin Alarcon

Andrew Badrot, C² PHARMA CEO, is interviewed by MJH Life Sciences during CPhI 2022 in Frankfurt and discusses the future of the company and the CMO industry in general

Posted on 24. November 202216. May 2023 by admin

Sarah Breen, Senior Quality Manager at C2 PHARMA, shares her thoughts on supplier oversight with Susan Haigney from Pharmaceutical Technology

Posted on 21. November 2022 by admin

C2 PHARMA Expands Ophthalmic API Portfolio with Tropicamide Launch & Multiple Regulatory Filings

Posted on 18. October 202216. May 2023 by admin

C² PHARMA at CPhI 2022 in Frankfurt

Posted on 3. October 20223. October 2022 by admin

What Goes Wrong When API Quality is Compromised?

Posted on 3. August 20223. October 2022 by admin

C2 PHARMA at CPhI 2021 in Milan

Posted on 2. November 20213. October 2022 by admin

Pharmaceutical reshoring: a healthy requirement, a strategic necessity – a Manufacturing Chemist Featured Story

Posted on 16. April 20213. October 2022 by admin

Andrew Badrot, C² PHARMA CEO, speaks on working to mitigate risks for future crises like the COVID-19 pandemic

Posted on 18. December 20203. October 2022 by admin

Interview with Andrew Badrot, C² PHARMA CEO, a “Lëtzebuerger Merkur” Featured Story

Posted on 19. November 202016. May 2023 by admin

C² PHARMA Finalist in Excellence in Pharma: Sustainability, the CPhI Pharma Awards 2020

Posted on 23. September 20203. October 2022 by admin

The Impact of Covid-19 on the Pharmaceutical Industry

Posted on 31. August 20203. October 2022 by admin

Connecting industry across the globe, a Chemicals Knowledge featured story

Posted on 27. August 20203. October 2022 by admin

Andrew Badrot, CEO of C² PHARMA, speaks on how the pharma industry has responded to the COVID-19 pandemic, a Pharma’s Almanac Q2 issue

Posted on 1. July 20203. October 2022 by admin

Lessons from a modern-day pandemic: redesigning the pharmaceutical supply chain, a Manufacturing Chemist featured story

Posted on 15. May 20203. October 2022 by admin

COVID-19/Coronavirus is reshaping the pharmaceutical supply chain

Posted on 27. April 20203. October 2022 by admin

C2 PHARMA Opens Government and Research Access to Safety Stock of DIGOXIN API for Use in Potential COVID-19/Coronavirus Combination Treatment

Posted on 26. March 20203. October 2022 by admin

Andrew Badrot, CEO of C2 PHARMA, weighs in on the future trends of mergers and acquisitions in the life sciences industry

Posted on 19. March 20203. October 2022 by admin

C2 PHARMA highlights importance of API quality

Posted on 19. February 20207. July 2020 by admin

Fairness in the pharma supply chain key to success in today’s business climate

Posted on 9. January 20202. October 2020 by admin

Andrew Badrot, CEO of C2 PHARMA, speaks on developing technologies that will have the greatest impact on the biopharma industry in 2020 and beyond, a Pharma’s Almanac Q4 issue

Posted on 6. December 201923. February 2021 by admin

C² PHARMA continues to expand API portfolio

Posted on 6. November 20192. October 2020 by admin

C² PHARMA Continues to Expand API Portfolio with Digoxin Micronized Grade, Homatropine Hydrobromide and Multiple Products Under Tech Transfer and Development

Posted on 4. November 201916. May 2023 by admin

C² PHARMA leverages virtual manufacturing to build secure supply chains, a Chemicals Knowledge featured story

Posted on 2. September 201923. February 2021 by admin

Why the industry is forming bonds with CBD

Posted on 1. July 2019 by admin

Building resilient supply chains for niche APIs How C² PHARMA overcame the Digoxin challenge

Posted on 6. June 20197. June 2019 by admin

FINANCIAL TIMES GLOBAL PHARMACEUTICAL AND BIOTECHNOLOGY CONFERENCE

Posted on 22. November 201823. February 2021 by admin

CPhI 2017: C² PHARMA acquires R&D synthesis services company and establishes cold-chain logistics spin-off

Posted on 16. October 201716. May 2023 by admin

Centroflora CMS changes its name to C² PHARMA

Posted on 4. October 201723. February 2021 by admin

CEP approval

Posted on 2. October 201716. May 2023 by admin

CPhI Award nomination

Posted on 20. September 201726. September 2018 by admin

Information Brief

Posted on 5. September 201725. September 2018 by admin

Finalist

Posted on 19. September 201612. January 2021 by admin

INFORMATION BRIEF

Posted on 9. September 201625. September 2018 by admin

Winner

Posted on 27. October 201512. January 2021 by admin

Major expansion

Posted on 4. October 201526. September 2018 by admin

Finalist

Posted on 21. September 201512. January 2021 by admin

Brazilian Pavillion

Posted on 1. September 201525. September 2018 by admin

Award

Posted on 22. May 201512. January 2021 by admin

CHEMICAL & ENGINEERING NEWS

Posted on 16. March 201512. January 2021 by admin

Paris

Posted on 1. September 20143. October 2022 by admin